TherapeuticsMD Inc. (NASDAQ: TXMD)
$1.3800
+0.0100 ( +1.47% ) 8.0K
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Market Data
Open
$1.3800
Previous close
$1.3700
Volume
8.0K
Market cap
$15.80M
Day range
$1.3700 - $1.4350
52 week range
$1.1500 - $2.9899
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 65 | Nov 12, 2024 |
8-k | 8K-related | 15 | Nov 12, 2024 |
def | Proxies and info statements | 10 | Oct 25, 2024 |
ars | Annual reports | 1 | Oct 25, 2024 |
8-k | 8K-related | 13 | Sep 20, 2024 |
4 | Insider transactions | 1 | Aug 26, 2024 |
4 | Insider transactions | 1 | Aug 23, 2024 |
10-q | Quarterly Reports | 65 | Aug 12, 2024 |
8-k | 8K-related | 15 | Aug 12, 2024 |
8-k | 8K-related | 16 | May 10, 2024 |